Experimental combo treatment worsens type 1 diabetes

August 24, 2012
Experimental combo treatment worsens type 1 diabetes
A treatment regimen that is effective in preventing diabetes in a mouse model of the disease leads to worsening disease in patients with type 1 diabetes, according to a study published online June 20 in Diabetes.

(HealthDay)—A treatment regimen that is effective in preventing diabetes in a mouse model of the disease leads to worsening disease in patients with type 1 diabetes, according to a study published online June 20 in Diabetes.

Following up on previous results in a mouse model of autoimmune diabetes showing that treatment with and interleukin-2 (IL-2) prevented the disease, S. Alice Long, Ph.D., from the Benaroya Research Institute in Seattle, and colleagues performed a phase I trial of oral rapamycin (daily for three months) and subcutaneous IL-2 (three times per week for one month) in nine patients with type 1 diabetes.

The researchers observed a transient worsening of diabetes (based on metabolic and clinical data) and β-cell function (based on C-peptide levels) in all subjects. There was a transient increase in the levels of regulatory T cells, but also an increase in and eosinophils. The frequencies of effector T-cell subsets were not affected.

"Thus, rapamycin/IL-2 therapy boosted , but also promoted a proinflammatory environment that may have resulted in transient β-cell dysfunction," Long and colleagues conclude. "Such results highlight the difficulties in translating therapies to the clinic and emphasize the importance of broadly interrogating the immune system to evaluate the effects of therapy."

Glucometers and test strips were donated by LifeScan. One author disclosed financial interests in Novartis.

Explore further: Oxygen treatment beneficial in diabetes-prone mice

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Oxygen treatment beneficial in diabetes-prone mice

May 8, 2012

(HealthDay) -- Hyperbaric oxygen treatment of a preclinical diabetes mouse model reduces the incidence of diabetes and preserves insulin-producing β-cells, according to a study published online May 7 in Diabetes.

Turmeric component reduces type 2 diabetes incidence

July 12, 2012

(HealthDay) -- A component of turmeric -- curcumin -- reduces the incidence of type 2 diabetes and improves β-cell function in adults with prediabetes, according to a study published online July 6 in Diabetes Care.

Recommended for you

Diabetes app forecasts blood sugar levels

April 27, 2017

Columbia University researchers have developed a personalized algorithm that predicts the impact of particular foods on an individual's blood sugar levels. The algorithm has been integrated into an app, Glucoracle, that will ...

New blood test may better predict gestational diabetes

April 27, 2017

A new study led by researchers at Brigham and Women's Hospital has found that a single measurement of plasma glycated CD59 (GCD59), a novel biomarker for diabetes, at weeks 24-28 of gestation identified, with high sensitivity ...

Post-biotics may help shield obese from diabetes

April 20, 2017

You've heard of pre-biotics and pro-biotics, but now you'll be hearing a lot more about post-biotics. Researchers at McMaster University have begun to identify how post-biotics, or the by-products of bacteria, lower blood ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.